Scaling opioid overdose prevention and naloxone dispensation among rural and small metro area pharmacists: findings from a qualitative study

[1]  B. Tofighi,et al.  Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019. , 2021, Journal of substance abuse treatment.

[2]  Christopher M. Jones,et al.  An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations , 2019, Journal of General Internal Medicine.

[3]  Christopher M. Jones,et al.  Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018 , 2019, MMWR. Morbidity and mortality weekly report.

[4]  David Powell,et al.  Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose. , 2019, JAMA internal medicine.

[5]  J. Baird,et al.  Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose , 2019, Journal of Urban Health.

[6]  P. Gruenewald,et al.  Urban-rural variation in the socioeconomic determinants of opioid overdose. , 2019, Drug and alcohol dependence.

[7]  P. Lichtenberger,et al.  A PrEP Model Incorporating Clinical Pharmacist Encounters and Antimicrobial Stewardship Program Oversight May Improve Retention in Care. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Courtney A. Roberts,et al.  Factors associated with how often community pharmacists offer and dispense naloxone. , 2019, Research in social & administrative pharmacy : RSAP.

[9]  Jing Xu,et al.  State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies. , 2018, Drug and alcohol dependence.

[10]  Shannon M. Monnat.  Factors Associated With County-Level Differences in U.S. Drug-Related Mortality Rates. , 2018, American journal of preventive medicine.

[11]  S. Nielsen,et al.  Naloxone rescheduling in Australia: Processes, implementation and challenges with supply of naloxone as a 'pharmacist only' over-the-counter medicine. , 2018, Drug and Alcohol Review.

[12]  L. Bakhireva,et al.  Barriers and Facilitators to Dispensing of Intranasal Naloxone by Pharmacists , 2018, Substance abuse.

[13]  C. Ruhm,et al.  Geographic Variation in Opioid and Heroin Involved Drug Poisoning Mortality Rates. , 2017, American journal of preventive medicine.

[14]  Victoriana Schwartz,et al.  Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. , 2017, Journal of the American Pharmacists Association : JAPhA.

[15]  B. Logan,et al.  Pharmacy-based statewide naloxone distribution: A novel "top-down, bottom-up" approach. , 2017, Journal of the American Pharmacists Association : JAPhA.

[16]  S. Nielsen,et al.  Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal. , 2016, Addiction.

[17]  S. Bird,et al.  Engagement in a National Naloxone Programme among people who inject drugs. , 2016, Drug and alcohol dependence.

[18]  C. Lewis,et al.  Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City. , 2015, Drug and alcohol dependence.

[19]  C. Fuller,et al.  Community Impact of Pharmacy-Randomized Intervention to Improve Access to Syringes and Services for Injection Drug Users , 2014, Health education & behavior : the official publication of the Society for Public Health Education.

[20]  Traci C. Green,et al.  The Feasibility of Pharmacy-Based Naloxone Distribution Interventions: A Qualitative Study With Injection Drug Users and Pharmacy Staff in Rhode Island , 2013, Substance use & misuse.

[21]  Al Ozonoff,et al.  Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis , 2013, BMJ.

[22]  Sarah Lippek,et al.  A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City. , 2010, AIDS education and prevention : official publication of the International Society for AIDS Education.

[23]  W. Hall,et al.  Heroin overdose: the case for take-home naloxone , 1996, BMJ.